{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/lacerations/management/laceration-infected/","result":{"pageContext":{"chapter":{"id":"9204ec1a-d022-5955-9f74-6b4eb51bf9a9","slug":"laceration-infected","fullItemName":"Scenario: Laceration - infected","depth":2,"htmlHeader":"<!-- begin field 238ba66c-912c-4f74-8389-7f801dd8017a --><h2>Scenario: Laceration - infected</h2><!-- end field 238ba66c-912c-4f74-8389-7f801dd8017a -->","summary":"Covers the management of a laceration that is already infected on presentation.","htmlStringContent":"<!-- begin item 72237db8-4743-42f5-9013-03b1984bc6ce --><!-- begin field 77218536-bdae-492b-9bea-acbd008538e6 --><p>From birth onwards.</p><!-- end field 77218536-bdae-492b-9bea-acbd008538e6 --><!-- end item 72237db8-4743-42f5-9013-03b1984bc6ce -->","topic":{"id":"bc1075da-03fb-510a-aafc-42f8402c77bb","topicId":"c455b3ad-86f5-4c2b-a00d-ceb66ba46f46","topicName":"Lacerations","slug":"lacerations","lastRevised":"Last revised in January 2021","chapters":[{"id":"abcb9c5e-8c70-578e-b2f1-2bfe9e0e6dea","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b3295eac-08d7-597e-9bbf-240c812490a5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0f6da996-76f9-5508-aead-4f7d04fc2910","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3713be7a-1d15-503e-9cdb-6d3afe60f335","slug":"changes","fullItemName":"Changes"},{"id":"d164a0e0-2763-5ec6-8aaa-1f68fe1d381c","slug":"update","fullItemName":"Update"}]},{"id":"e6d917bb-ce9e-58a6-8b13-cf3e389a6aef","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"83820372-5bd1-5e60-a139-cd76615ac683","slug":"goals","fullItemName":"Goals"},{"id":"15606cb7-089f-5a7d-af3f-d4b9c9b0d2be","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1a9aa28b-0708-5c58-843c-05a09196b471","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"682e483f-7847-5e82-be10-969f896d9533","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0db2153f-bcb4-5382-9178-92d651a01c4e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3929f359-184e-53d4-8aca-a4081b967c1a","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"313e7f7d-a625-5b48-a31d-e5f00ca31462","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"0ad26899-0f07-5523-8ea6-17d520df4cc8","slug":"definition","fullItemName":"Definition"},{"id":"e917af1e-ca7f-5ddd-9cb9-1132ce21b4a9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fe57a056-8e82-56fa-bb79-87f037fb4303","slug":"complications","fullItemName":"Complications"}]},{"id":"e01eac70-aab4-50c3-a90e-7b07194bf1c8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c1be68cd-346e-504f-b22f-e8352fc5c3f6","slug":"assessment","fullItemName":"Assessment"}]},{"id":"35a250d2-9a3b-5287-8afa-d73dfc12c39b","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c6adc10-cc7f-5820-b2da-874e89c9b72b","slug":"laceration-low-infection-risk","fullItemName":"Scenario: Laceration - low infection risk"},{"id":"496fa19f-131c-5dd3-8be3-ae041478b608","slug":"laceration-high-infection-risk","fullItemName":"Scenario: Laceration - high infection risk"},{"id":"9204ec1a-d022-5955-9f74-6b4eb51bf9a9","slug":"laceration-infected","fullItemName":"Scenario: Laceration - infected"}]},{"id":"ae2f2d25-ab30-53a1-8eff-d3fb8c5994f9","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ffdfa8df-e6e7-56b4-99c6-dfe62dda65a2","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"f4667375-a12d-57c4-a82a-192c500b41bb","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"8d7c7214-71fc-5171-9875-f310b20c40cb","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"23d49e6f-7a37-5188-8b3f-6b6fdb671019","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"f3f77580-8498-590e-a7c3-0afbee563567","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"8f912e41-1ff8-5fce-b9b4-6b3524e8f79b","slug":"tetanus-booster","fullItemName":"Tetanus booster"}]},{"id":"b1fc897d-bfab-5305-bcf1-70e0f4598e5a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"18a38028-bff4-54de-948c-9715f3649589","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0132c748-edac-513b-a351-59a838b07e61","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b4b28cd4-4652-528e-aa28-23f341c6a31e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b86d931b-dadb-55a7-92c8-6cdb81ce5d7f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f6695afc-2f21-5bf7-907b-68a0fb3a77c4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d4ab79d3-d601-5b9b-b2b5-d3256e138671","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"bc9ca4ec-c56f-5acc-830c-ccf5c31d5f67","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"35a250d2-9a3b-5287-8afa-d73dfc12c39b","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"7988e6e3-7671-5281-87b4-50bc23c28e90","slug":"initial-management","fullItemName":"Initial management","depth":3,"htmlHeader":"<!-- begin field ab61a0b9-fb06-48e4-8aa1-f7c4e1d018bb --><h3>How should I manage an infected laceration?</h3><!-- end field ab61a0b9-fb06-48e4-8aa1-f7c4e1d018bb -->","summary":null,"htmlStringContent":"<!-- begin item 451f842c-0066-43f4-8f21-dfa90bb84517 --><!-- begin field 23bb39f1-5f64-4da2-a986-1fa12b266281 --><p><strong>These recommendations are intended as a brief guide as lacerations should be managed by a professional with experience in wound management. If the expertise is not available in primary care, refer the person to A&E.</strong></p><p><strong>Provided <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/diagnosis/assessment/\">immediate admission or referral to A&amp;E</a> is not indicated:</strong></p><ul><li><strong>Clean the wound.</strong><ul><li>Disinfect the skin around the wound with an antiseptic, but avoid getting antiseptic into the wound.</li><li>Keep hair out of the wound — if necessary, clip the hair around the wound with scissors (rather than shaving) and apply simple ointment to flatten any remaining hair away from the wound.</li><li>If debriding or exploring the wound, anaesthetize the area. The pain from infiltrating local anaesthetic can be reduced by:<ul><li>Using a 25–gauge needle.</li><li>Warming the anaesthetic before infiltration.</li><li>Infiltrating through the cut edge of the wound into the subdermal tissue.</li><li>Infiltrating slowly.</li></ul></li><li>Debride devitalized tissue, and pick out as much foreign material as possible.<ul><li>Refer for radiography if there is a possible foreign body remaining in the wound after cleaning, including all injuries caused by glass.</li></ul></li><li>Irrigate the wound with normal saline, drinking-quality water, or cooled boiled water. <ul><li>For lacerations that are visibly contaminated, irrigate at high pressure with a syringe and a green needle to remove visible debris from the wound.</li></ul></li></ul></li><li><strong>Dress but <em>do not </em>close the wound.</strong><ul><li>Prevent apposition of the wound edges by packing with a non-adherent dressing.</li><li>Cover all lacerations with a non-adherent, absorbent dressing.<ul><li>For lacerations with small quantities of exudate, dress with a non-adherent dressing alone or cover the non-adherent dressing with a vapour-permeable dressing.</li><li>For lacerations with more exudate, cover the non-adherent dressing with an alginate dressing or with a foam dressing.</li></ul></li><li>See the <a href=\"https://bnf.nice.org.uk/\" data-hyperlink-id=\"bc934ebe-d46b-4103-ac1d-a98c0147ae64\">British National Formulary</a> (BNF) for information on the different dressings available on the NHS.</li></ul></li><li><strong>Prescribe antibiotic treatment for 5–7 days. </strong>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/management/laceration-infected/#which-antibiotic-to-prescribe\">Antibiotics</a> for more information.</li><li><strong>Check the person's tetanus immunization status to determine the need for a booster dose of tetanus vaccine.</strong><ul><li>Refer people with a tetanus-prone wound to hospital for treatment with human tetanus immunoglobulin, regardless of tetanus immunization status.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/management/laceration-infected/#tetanus-prophylaxis\">Tetanus prophylaxis</a> for more information.</li></ul></li><li><strong>Provide verbal and written advice to the person, including to: </strong><ul><li>Seek medical attention if the infection persists or worsens.</li><li>Take simple analgesia, such as paracetamol or ibuprofen, if the wound is painful or is likely to become painful. For detailed prescribing information on paracetamol and ibuprofen, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a>.</li><li>Keep the wound clean and dry.<ul><li>Waterproof dressings, such as vapour-permeable dressings, allow light wetting (as from showering) without the dressing separating or the wound becoming wet.</li><li>Non-waterproof dressings must be protected from wetting at all times.</li></ul></li></ul></li><li><strong>Review the person 3–5 days after presentation to assess whether the wound can be closed.</strong> See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/management/laceration-infected/#follow-up\">Follow up</a> for more information.</li></ul><!-- end field 23bb39f1-5f64-4da2-a986-1fa12b266281 --><!-- end item 451f842c-0066-43f4-8f21-dfa90bb84517 -->","subChapters":[{"id":"22b91142-edcc-5241-a807-0f9c95ce80b4","slug":"basis-for-recommendation-0c7","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4df3383b-70eb-43b1-8f12-70ed8b6ef6f2 --><h4>Basis for recommendation</h4><!-- end field 4df3383b-70eb-43b1-8f12-70ed8b6ef6f2 -->","summary":null,"htmlStringContent":"<!-- begin item 0c7ea313-8b82-4692-8a1e-cb17b5acb5e4 --><!-- begin field 6b4b1091-4a31-4e3d-8b43-b17ca9cad34e --><h5>Cleaning the wound</h5><ul><li>Evidence from prospective studies shows that devitalized tissue, foreign bodies, and visible contamination of a laceration increase the risk of wound infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Cruse and Foord, 1980</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Hollander et al, 2001</a>].</li><li>Although there is a lack of direct evidence for the effectiveness of measures to clean the wound (such as removal of hair and foreign bodies, disinfection of the surrounding skin, debridement and irrigation of the wound) in reducing infection rates in lacerations, they are practical recommendations that are widely recommended [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Edlich and Reddy, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">NGC, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Cals, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Worster, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">DynaMed, 2016</a>]. </li><li>Evidence from a Cochrane systematic review (search date: November 2011) found that drinkable tap water, boiled and cooled water, and normal saline are all comparable wound cleansing agents and that using drinkable tap water to clean acute wounds does not appear to increase the infection rate [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Fernandez and Griffiths, 2012</a>].</li><li>A second Cochrane systematic review (search date: December 2016) found that topical anaesthetics provided effective analgesic efficacy during repair of dermal lacerations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Tayeb, 2017</a>].</li></ul><h5>Dressing and packing the wound</h5><ul><li>These recommendations are based on information in the British National Formulary (BNF) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">BNF 72, 2016</a>]. CKS recommends the use of different categories of dressings, but not specific dressings. The exact dressing used will depend on personal preference and experience. <ul><li>Low adherence, absorbent dressings are recommended for wounds with small quantities of exudate because:<ul><li>They can absorb small quantities of exudate, which prevents the wound from becoming macerated but maintains a moist environment for optimal wound healing.</li><li>Exudate from the wound discolours the dressing and is easily seen. This allows some monitoring of the wound without removing the dressing.</li></ul></li><li>Alginate or foam dressing is recommended for wounds with moderate or heavier quantities of exudate because these have a greater capacity to absorb exudate.</li></ul></li></ul><h5>Antibiotic treatment</h5><ul><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/management/laceration-infected/#which-antibiotic-to-prescribe\">Antibiotics</a> for more information.</li></ul><h5>Tetanus immunization </h5><ul><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/management/laceration-infected/#tetanus-prophylaxis\">Tetanus prophylaxis</a> for more information.</li></ul><h5>Providing advice</h5><ul><li><p>This recommendation is based on expert opinion in review articles on laceration repair and management [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Hollander and Singer, 1999</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Wilson et al, 2000</a>].</p></li></ul><!-- end field 6b4b1091-4a31-4e3d-8b43-b17ca9cad34e --><!-- end item 0c7ea313-8b82-4692-8a1e-cb17b5acb5e4 -->","subChapters":[]}]},{"id":"172a652a-1b26-5a7a-abd5-7e5472e4b284","slug":"which-antibiotic-to-prescribe","fullItemName":"Which antibiotic to prescribe","depth":3,"htmlHeader":"<!-- begin field bab7d6d0-eb19-4526-aaaa-ad074434d161 --><h3>Which antibiotic should I prescribe for an infected laceration?</h3><!-- end field bab7d6d0-eb19-4526-aaaa-ad074434d161 -->","summary":null,"htmlStringContent":"<!-- begin item 0e3d0f6c-2b1e-41f0-9242-b0389cf6ec83 --><!-- begin field 2e75754a-9da5-4295-aaf7-5947c8e22757 --><ul><li><strong>Take a detailed history and ascertain whether the wound was originally contaminated with high-risk material (soil, faeces, saliva, or purulent exudates).</strong><ul><li><strong>For contaminated wounds, </strong>treat with co-amoxiclav.<ul><li>If the person is allergic to penicillin, treat with erythromycin or clarithromycin combined with metronidazole.</li></ul></li><li><strong>For clean wounds (that is, wounds with no history or evidence of contamination or foreign bodies), </strong>treat with flucloxacillin. <ul><li>If the person is allergic to penicillin, treat with erythromycin or clarithromycin.</li></ul></li><li>For detailed information on prescribing these antibiotics, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/prescribing-information/\">Prescribing information</a>.</li></ul></li><li><strong>Take a swab of the wound <em>before</em> starting antibiotic treatment.</strong></li></ul><!-- end field 2e75754a-9da5-4295-aaf7-5947c8e22757 --><!-- end item 0e3d0f6c-2b1e-41f0-9242-b0389cf6ec83 -->","subChapters":[{"id":"30ed94e0-1b47-5fc3-8754-42fe0e0e3280","slug":"basis-for-recommendation-da8","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field aaa7df0b-3bf2-46d0-a8dc-37a068c38c92 --><h4>Basis for recommendation</h4><!-- end field aaa7df0b-3bf2-46d0-a8dc-37a068c38c92 -->","summary":null,"htmlStringContent":"<!-- begin item da8b3066-d0cf-4734-8f69-3fad41859778 --><!-- begin field 198f9723-5bbc-45d6-9df4-5c9e4124bb9e --><h5>Antibiotic choices</h5><ul><li>These recommendations are based on the common use of antibiotics in the UK and the known antibiotic sensitivities of bacteria likely to present in a contaminated or susceptible wound.<ul><li><strong>Co-amoxiclav </strong>is a broad-spectrum antibiotic licensed for the treatment of skin and soft-tissue infections. It is effective against many species of Gram-positive and Gram-negative bacteria in addition to many anaerobes. It is also effective against penicillinase-producing bacteria, including resistant <em>Staphylococcus aureus </em>and <em>S. epidermis </em>(which commonly colonize skin) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">ABPI, 2017a</a>]. <ul><li>Wounds that are, or may have been, contaminated with potentially infectious material (soil, faeces, body fluids, or pus) require a broad-spectrum antibiotic to cover the large number of species of bacteria which may be involved.</li></ul></li><li><strong>Flucloxacillin </strong>is licensed for the treatment of infected skin conditions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">ABPI, 2016a</a>]. It has a narrow spectrum of activity but is active against species normally found in the skin as commensals, which are the most likely causative pathogens in a 'clean' wound that becomes infected. It is therefore suitable for treatment of clean wounds at higher risk of infection.<ul><li>The most common bacteria involved in pathogenesis are <em>S. aureus </em>and <em>S. epidermis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Edlich and Reddy, 2001</a>], both of which are susceptible to flucloxacillin.</li><li>Flucloxacillin diffuses well into most tissues and is therefore suitable for skin and soft-tissue infections, including those in lacerations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Finch et al, 2003</a>].</li></ul></li><li><strong>Erythromycin </strong>is licensed for the treatment of soft-tissue infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">ABPI, 2015</a>].<strong> </strong>It has a broad spectrum of activity and is a suitable alternative to flucloxacillin and co-amoxiclav (when combined with metronidazole).<ul><li>The spectrum of activity of erythromycin includes activity against most sensitive Gram-positive cocci (including <em>S. aureus </em>and <em>S. epidermis</em>) and some Gram-negative cocci and anaerobes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Finch et al, 2003</a>].</li></ul></li><li><strong>Clarithromycin </strong>has a similar spectrum of activity to erythromycin but is reputed to cause fewer adverse effects [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">DTB, 1991b</a>]. </li><li><strong>Metronidazole </strong>is indicated for the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">ABPI, 2017b</a>]. It provides additional coverage for anaerobes that are not susceptible to erythromycin or clarithromycin. </li></ul></li></ul><h5>Taking a swab before starting antibiotic treatment</h5><ul><li>This recommendation is based on what CKS considers to be good clinical practice. If empirical antibiotic treatment is ineffective, the result of the swab can be used to determine the most appropriate antibiotic treatment.</li></ul><!-- end field 198f9723-5bbc-45d6-9df4-5c9e4124bb9e --><!-- end item da8b3066-d0cf-4734-8f69-3fad41859778 -->","subChapters":[]}]},{"id":"7c2f3077-6c0b-555a-a89a-6593757aa4e0","slug":"tetanus-prophylaxis","fullItemName":"Tetanus prophylaxis","depth":3,"htmlHeader":"<!-- begin field 05633fe9-eae4-493a-82fa-f721a7d26655 --><h3>When should I give tetanus prophylaxis to a person with an infected laceration?</h3><!-- end field 05633fe9-eae4-493a-82fa-f721a7d26655 -->","summary":null,"htmlStringContent":"<!-- begin item 963fd4df-1016-4931-bbab-05641d5d9c6d --><!-- begin field a8c4c384-31e5-48b7-849b-1a13709cd778 --><ul><li><strong>Check the person's tetanus immunization status.</strong><ul><li>A fully immunized person will have had a primary course of three vaccines followed by two boosters spaced 10 years apart. For further details, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li></ul></li><li><strong>Refer people with a tetanus-prone wound to hospital for treatment with human tetanus immunoglobulin,</strong> regardless of tetanus immunization status.<ul><li>Tetanus-prone wounds include:<ul><li>Wounds that require surgical intervention that is delayed for more than six hours.</li><li>Wounds that show a significant degree of devitalised tissue or a puncture-type injury, particularly where there has been contact with material likely to contain tetanus spores (for example soil or manure).</li><li>Wounds containing foreign bodies.</li><li>Compound fractures.</li><li>Wounds in people who have systemic sepsis.</li></ul></li></ul></li><li><strong>For all other people, a</strong><strong>dminister a booster dose of tetanus vaccine if needed.</strong><ul><li><strong>If the person is fully immunized,</strong> a booster dose is not required.</li><li><strong>If primary immunization is complete but boosters are incomplete but up to date,</strong> a booster dose is not required, but administer if the next dose is due soon and it is convenient to do so.</li><li><strong>If primary immunization is incomplete or boosters are not up to date, </strong>administer a reinforcing dose of the vaccine, and continue with the recommended schedule (to ensure future immunity).</li><li><strong>If the person is not immunized or the immunization status is unknown or uncertain,</strong> give an immediate dose of vaccine followed, if records confirm the need, by completion of a full five-dose course to ensure future immunity.</li><li>For details on giving a booster dose of tetanus vaccine, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/prescribing-information/tetanus-booster/\">Tetanus booster</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/prescribing-information/\">Prescribing information</a>.</li></ul></li></ul><!-- end field a8c4c384-31e5-48b7-849b-1a13709cd778 --><!-- end item 963fd4df-1016-4931-bbab-05641d5d9c6d -->","subChapters":[{"id":"9fd2eb75-b4e3-5d31-8c47-9d099117addb","slug":"basis-for-recommendation-c51","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2a52afbb-23a7-4166-bfe5-00510caea667 --><h4>Basis for recommendation</h4><!-- end field 2a52afbb-23a7-4166-bfe5-00510caea667 -->","summary":null,"htmlStringContent":"<!-- begin item c513059f-ce5c-4b89-8209-8e2bbc4f5d73 --><!-- begin field 236e84ff-0f6a-4c50-85d6-f02e3ad6952c --><ul><li>These recommendations are based on information in <em>Tetanus: the green book, chapter 30</em> published by Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">PHE, 2013</a>], which states that:<ul><li>Tetanus vaccine given at the time of a tetanus-prone injury may not boost immunity early enough to give additional protection if a tetanus-prone wound is present. </li><li>The use of immunoglobulins is a precautionary recommendation as evidence to support other alternatives is insufficient.</li></ul></li><li>Human tetanus immunoglobulin is unlikely to be available in primary care and will usually require referral to A&E.</li></ul><!-- end field 236e84ff-0f6a-4c50-85d6-f02e3ad6952c --><!-- end item c513059f-ce5c-4b89-8209-8e2bbc4f5d73 -->","subChapters":[]}]},{"id":"830096b6-ce1b-5b0f-83da-524457cf78f4","slug":"follow-up","fullItemName":"Follow up","depth":3,"htmlHeader":"<!-- begin field 6f1acf4d-4efb-4e6e-b9e0-a77500e0a1ca --><h3>How should I follow up a person with an infected laceration?</h3><!-- end field 6f1acf4d-4efb-4e6e-b9e0-a77500e0a1ca -->","summary":null,"htmlStringContent":"<!-- begin item aea53c7e-4c6c-4805-bb00-a77500e09c08 --><!-- begin field 6064dfd4-2ccb-4794-b8d8-a77500e0a1ca --><p><strong>These recommendations are intended as a brief guide as lacerations should be managed by a professional with expertise in wound management. If the expertise is not available in primary care, refer the person to A&E.</strong></p><ul><li><strong>Review the person 3–</strong><strong>5 days after presentation to assess whether the wound can be closed.</strong> </li><li><strong>If signs of infection persist:</strong><ul><li>Review the swab results, change the antibiotics if indicated, and arrange further review. </li></ul></li><li><strong>If there are no signs of an infection:</strong><ul><li><strong>Close the wound. </strong><ul><li>Consider the most appropriate method, taking into account the location and severity of the wound, the available expertise and materials, and the age, health, and preference of the person with the wound. </li><li>Suturing (with local anaesthetic) is preferred for wounds longer than 5 cm, or those 5 cm or shorter when deep dermal sutures are required (to allow low-tension apposition of the wound edges) or when the wound is subject to excessive flexing and tension (such as over joints or thick dermis), or wetting.</li><li>Adhesive strips should be used to close wounds 5 cm or shorter when there are no <a class=\"topic-reference internal-reference\" href=\"/topics/lacerations/background-information/complications/\">risk factors</a> for infection, <em>and </em>the wound edges are easily apposed without leaving any dead space, <em>and </em>the wound is not subject to excessive flexing, tension, or wetting. Adhesive strips are also appropriate for use in pretibial flaps.</li></ul></li><li><strong>Apply a dressing after closing the wound.</strong><ul><li>For lacerations with minimal exudate, dress with a clear vapour-permeable dressing.</li><li>For lacerations with modest exudate, dress with a low adherence, absorbent, perforated dressing with an adhesive border. These are also available with a plastic film covering to protect dressings from getting wet.</li><li>See the <a href=\"https://bnf.nice.org.uk/\" data-hyperlink-id=\"793bafa3-60c8-4ef7-a803-a9910027fdee\">British National Formulary</a> (BNF) for information on the different dressings available on the NHS.</li></ul></li><li><strong>If necessary, arrange a follow-up appointment to remove the wound closure.</strong><ul><li><strong>For lacerations closed by sutures, </strong>remove stitches after 3–5 days for wounds on the head, 10–14 days for wounds over joints, and 7–10 days for wounds at other sites.</li><li><strong>For lacerations closed by adhesive strips, </strong>advise the person to remove these themselves after 3–5 days for wounds on the head and 7–10 days for wounds at other sites.</li><li>Remove dressings when sutures or adhesive strips are due to be removed. Low-adherence absorbent dressings should be replaced if exudate has caused significant wetting of the dressing.</li></ul></li></ul></li></ul><!-- end field 6064dfd4-2ccb-4794-b8d8-a77500e0a1ca --><!-- end item aea53c7e-4c6c-4805-bb00-a77500e09c08 -->","subChapters":[{"id":"5de8a6eb-4747-5bd2-92ac-537aaa6309e7","slug":"basis-for-recommendation-69e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a6c40a17-d04e-4f74-87eb-a77500e0a1cf --><h4>Basis for recommendation</h4><!-- end field a6c40a17-d04e-4f74-87eb-a77500e0a1cf -->","summary":null,"htmlStringContent":"<!-- begin item 69e1dff3-9d80-409d-9280-a77500e0a1cf --><!-- begin field b6a9df84-636f-408d-ada9-a77500e0a1cf --><h5>When to close the wound</h5><ul><li>Experts widely recommend delayed closure when lacerations are infected [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Hollander and Singer, 1999</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Edlich and Reddy, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Richardson, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Cals, 2012</a>]. The recommendation to wait 3–5 days is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Cals, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">DynaMed, 2016</a>].</li></ul><h5>How to close the wound</h5><ul><li>Information on skin closure methods is largely based on expert opinion in review articles on laceration management [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Worster, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">DynaMed, 2016</a>]. <ul><li>Adhesive strips are recommended because they are easily removed if infection develops. In addition, evidence from a randomized controlled trial (n = 100) indicates that skin closure strips have very similar outcomes as tissue adhesives when used to close simple facial lacerations in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Zempsky et al, 2004</a>].</li><li>Tissue adhesives are not recommended for delayed closure of lacerations at high risk of infection because they are not easily removed to allow drainage.</li></ul></li><li>CKS does not recommend the use of staples in primary care because they produce a poorer cosmetic result than other methods of closure. Although they are quicker to use than other methods of closure, this is rarely a significant factor in primary care (compared with a busy casualty department where this is a significant benefit) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Cole, 2003</a>].</li></ul><h5>Choice of dressing after closing the laceration</h5><ul><li>These recommendations are based on information in the British National Formulary (BNF) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">BNF 72, 2016</a>]. CKS recommends the use of different categories of dressings, but not specific dressings. The exact dressing used will depend on personal preference and experience.<ul><li>Vapour-permeable film dressings are recommended for use with wounds with low levels of exudate because:<ul><li>They are waterproof and protect the wound from becoming infected or wet during normal daily activities.</li><li>They maintain a moist environment for optimal wound healing.</li><li>They are comfortable and convenient to use.</li><li>They allow the wound to be visually inspected for infection without the dressings being removed.</li></ul></li><li>Low-adherence, absorbent, perforated dressings are recommended for wounds with moderate amounts of exudate because:<ul><li>They can absorb moderate amounts of exudate, which prevents the wound from becoming macerated but maintains a moist environment for optimal wound healing.</li><li>Exudate from the wound discolours the dressing and is easily seen. This allows some monitoring of the wound without removing the dressing.</li></ul></li></ul></li></ul><h5>Information on wound closure removal</h5><ul><li>These recommendations are based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Singer et al, 1997</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Cals, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">DynaMed, 2016</a>].<ul><li>Generally, the greater the tension across the wound, the longer the suture should be left for [<a class=\"bibliography-reference internal-reference\" href=\"/topics/lacerations/references/\">Cals, 2012</a>].</li></ul></li></ul><!-- end field b6a9df84-636f-408d-ada9-a77500e0a1cf --><!-- end item 69e1dff3-9d80-409d-9280-a77500e0a1cf -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}